Core Viewpoint - The establishment of the "China Hemophilia Treatment Center" at Yantai Yuhuangding Hospital marks a significant advancement in the treatment and management of hemophilia, aiming to enhance the overall care for patients through a multidisciplinary approach [1][2][3] Group 1: Establishment and Significance - The "China Hemophilia Treatment Center" was officially recognized during a recent evaluation and awarding ceremony at Yantai Yuhuangding Hospital, attended by experts and hospital officials [1] - The center's establishment is expected to consolidate expertise across various disciplines to explore advanced treatment methods and improve the overall standard of care for hemophilia patients [1] Group 2: Evaluation Process - The evaluation process involved a comprehensive review by a team of experts who assessed multiple aspects of the treatment center, including patient information registration, diagnosis, treatment, laboratory testing, and emergency care protocols [2] - The evaluation lasted nearly six months, during which the China Rare Disease Alliance organized assessments from authoritative experts across various dimensions such as treatment standards and team management [2] Group 3: Recognition and Future Plans - Yantai Yuhuangding Hospital received high praise from the expert panel for its well-established multidisciplinary collaboration mechanism, advanced diagnostic equipment, and professional technical team, meeting national standards for hemophilia treatment centers [3] - The hospital's leadership expressed that this recognition serves as both an affirmation of past efforts and a motivation for future improvements in hemophilia care, aiming to provide superior medical services to patients in the region [3]

Core Viewpoint - The establishment of the "China Hemophilia Treatment Center" at Yantai Yuhuangding Hospital marks a significant advancement in the treatment and management of hemophilia, a rare and complex disease, enhancing the overall diagnostic and therapeutic capabilities for patients in the region [1][5]. Group 1: Event Overview - The on-site evaluation and awarding ceremony for the "China Hemophilia Treatment Center" took place at Yantai Yuhuangding Hospital, attended by experts from the China Hemophilia Alliance and other medical professionals [1]. - The event included a comprehensive assessment of the hospital's capabilities in treating hemophilia, involving multiple clinical departments and specialists [3][5]. Group 2: Expert Evaluation - Experts conducted thorough evaluations of various aspects of hemophilia treatment, including patient information registration, diagnosis, laboratory testing, drug supply, multidisciplinary collaboration, emergency treatment processes, rehabilitation, and follow-up education [3][5]. - The evaluation process lasted nearly six months, with a focus on treatment standards, equipment configuration, team building, and patient management [5]. Group 3: Recognition and Future Plans - Yantai Yuhuangding Hospital successfully passed the certification process, becoming the first medical institution in Yantai and Weifang to receive national-level hemophilia treatment certification [5]. - The hospital's leadership expressed commitment to further improving the hemophilia treatment system and providing high-quality medical services to patients in Yantai and surrounding provinces [9].